Dymista Allergen Chamber - Onset of Action Study
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3; Drug: Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 5; Drug: Treatment A (Dymista): Fixed drug combination of azelastine hy drochloride and fluticasone propionate nasal spray at Visit 5; Drug: Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 3 Sponsor: MEDA Pharma GmbH & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial)
DiscussionThis RCT will provide evidence on whether oral corticosteroids are beneficial and safe in patients with post-infectious cough. Results can have a substantial impact on the well-being and management of these patients in Switzerland and beyond. An evidence-based treatment for this condition may reduce re-consultations with GPs and spending for antitussive drugs, thus possibly having an impact on health care spending.Trial registrationClinicalTrials.govNCT04232449. Prospectively registered on 18 January 2020. (Source: Trials)
Source: Trials - November 23, 2020 Category: Research Source Type: clinical trials
Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
Condition: Allergic Rhinitis Interventions: Drug: Fluticasone Propionate; Drug: Azelastine hydrochloride and fluticasone propionate; Drug: Rupatadine Sponsor: St. Paul's Sinus Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2020 Category: Research Source Type: clinical trials
